Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.
Also called NCT05399680
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 151 participants
- Sponsor
- Registry
-
NCT05399680
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Austria, Belgium, France, Italy, Spain, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT05399680. Allocation not applicable; no masking; primary purpose treatment. Start 2022-06-29 (actual); primary completion 2023-09-22 (actual). Results posted on 2025-08-11.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access
- Acronym
- RADIANCY
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- S.M.A.R.T. RADIANZ™ Vascular Stent System
- Intervention (Device)
- BRITE TIP RADIANZ™ Guiding Sheath
- Intervention (Device)
- SABERX RADIANZ™ PTA Balloon Catheter
- Lead sponsor
- Cordis US Corp.
- Collaborator
- Qserve
- Collaborator
- NAMSA
Record details
- Record id
cardio:ct-nct05399680- Content hash
e1c617891cbbb577e928fbff013d14072a484bdfd994bdacd8f0285161aa29f7